Daniel Chao

Daniel Chao is a neurotech entrepreneur, specializing in devices that improve brain performance. Currently, Dan is co-founder and CEO of Halo Neuroscience, a venture-backed human performance company based in San Francisco. The company's first product, Halo Sport, is the world's first neurostimulation system built specifically for athletes. Prior to Halo, Dan was the head of business development at NeuroPace, where he helped raise $250M in capital to develop the world's first closed-loop neuromodulation device, winning FDA approval for the treatment of epilepsy in a unanimous 13-0 vote. Before NeuroPace, Dan was a consultant at McKinsey & Company in the New York office, and he received his M.D. and M.S. in neuroscience from Stanford University.